Directs the Secretary of Health and Human Services to issue guidance by January 1, 2026, on Medicare payment requirements under part B of title XVIII of the Social Security Act for remote monitoring devices. Mandates that the guidance specifically address devices that incorporate artificial intelligence components, such as continuous adjustment features. Requires that these devices must transmit information to healthcare providers for the management and treatment of individuals to qualify for payment.
Paper
Full text
Maintaining Innovation and Safe Technologies Act
ETO AGORA · U.S. federal laws · 2024
Summary
Directs the Secretary of Health and Human Services to issue guidance by January 1, 2026, on Medicare payment requirements under part B of title XVIII of the Social Security Act for remote monitoring devices.
Mandates that the guidance specifically address devices that incorporate artificial intelligence components, such as continuous adjustment features.
Requires that these devices must transmit information to healthcare providers for the management and treatment of individuals to qualify for payment.
Segment 1
A BILL To direct the Secretary of Health and Human Services to issue guidance on payment under the Medicare program for certain items involving artificial intelligence.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
Requires the Secretary of Health and Human Services to issue guidance on requirements for payment for remote monitoring devices that use an artificial intelligence component.
SECTION 1. Short title.
This Act may be cited as the “Maintaining Innovation and Safe Technologies Act”.
SEC. 2. Guidance on Medicare payment for certain items involving artificial intelligence.
Not later than January 1, 2026, the Secretary of Health and Human Services shall use existing communications mechanisms to issue guidance on requirements for payment under part B of title XVIII of the Social Security Act (42 U.S.C. 1395j et seq.) for remote monitoring devices, such as continuous glucose monitors, that—
(1) use an artificial intelligence component (such as a continuous adjustment component); and
(2) transmit information to a health care provider for purposes of management and treatment of an individual.